Robert N. Weinreb, MD.

SAN DIEGO—Toku has announced the appointment of Robert N. Weinreb, MD, to its board of directors. A technology company specializing in developing non-invasive, artificial intelligence (AI)-powered diagnostic and screening tools using retinal imaging to measure cardiovascular and other health risk factors, Toku noted that Dr. Weinreb's appointment underscores the company's commitment to excellence and innovation in eyecare. “We are thrilled to welcome Dr. Weinreb to our board. Working with him, we will accelerate our leadership in health care through the eye,” according to Ehsan Vaghefi, Toku president and chief executive officer.

Renowned for his contributions to ophthalmology, Dr. Weinreb brings with him a career that encompasses groundbreaking research and clinical practice. He was previously chair and distinguished professor of ophthalmology at the University of California, San Diego, and director of the Shiley Eye Institute and the Hamilton Glaucoma Center. It was also recently announced that Dr. Weinreb joined the Ophthalmologist Power List Hall of Fame.

“I am excited to join Toku's board of directors,” said Dr. Weinreb. “The company's groundbreaking work is certain to have a meaningful impact on the lives of patients throughout the world.”